Time-to-onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosis

Oral bisphosphonates reduce fracture risk in osteoporotic patients but are often associated with poor compliance, which may impair their antifracture effects. This post-hoc analysis assessed the time-to-onset and persistence of the antifracture effect of zoledronic acid, a once-yearly bisphosphonate...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Boonen, Steven, Eastell, Richard, Su, Guoqin, Mesenbrink, Peter, Cosman, Felicia, Cauley, Jane A., Reid, Ian R, Claessens, Frank, Vanderschueren, Dirk, Lyles, Kenneth W, Black, Dennis M
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3636532/
https://ncbi.nlm.nih.gov/pubmed/22431413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.1605
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky